New SARS-CoV-2 Variant Could Evade Antibodies
New SARS-CoV-2 Variant Could Evade Antibodies
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.
New SARS-CoV-2 Variant Could Evade Antibodies
New SARS-CoV-2 Variant Could Evade Antibodies

A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.

A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.

COVID-19
Q&A: Natural History Museums’ Role in Pandemic Surveillance
Q&A: Natural History Museums’ Role in Pandemic Surveillance
Max Kozlov | Jan 21, 2021
Host vouchering, the practice of preserving species known to harbor infectious diseases, can be used to help determine a pathogen’s source, scientists say.
Special Report
COVID-19’s Effects on the Brain
COVID-19’s Effects on the Brain
Katarina Zimmer | Jan 20, 2021
Autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms.
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Asher Jones | Jan 19, 2021
It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.
Past SARS-CoV-2 Infection Mostly Protects Survivors
Past SARS-CoV-2 Infection Mostly Protects Survivors
Max Kozlov | Jan 14, 2021
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
Max Kozlov | Jan 14, 2021
Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.
US Confirms World’s First SARS-CoV-2 Cases in Gorillas
US Confirms World’s First SARS-CoV-2 Cases in Gorillas
Max Kozlov | Jan 12, 2021
Zoo officials say the captive primates are recovering, but scientists worry the virus could spread quickly through dwindling wild populations.
Julius Schachter, Renowned Chlamydia Researcher, Dies at 84
Julius Schachter, Renowned Chlamydia Researcher, Dies at 84
Max Kozlov | Jan 12, 2021
The UCSF microbiologist pioneered investigations into the deadly disease starting in the late 1960s that have led to the near eradication of trachoma, a chlamydia-related eye infection.
Pregnant COVID-19 Patients
Pregnant COVID-19 Patients
The Scientist Staff | Jan 11, 2021
See a news report on a study of expectant mothers with SARS-CoV-2 infections.
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
Asher Jones | Jan 11, 2021
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.